NVAX logo

Novavax (NVAX) Cost of goods sold

annual cost of goods sold:

$202.74M-$141.03M(-41.02%)
December 31, 2024

Summary

  • As of today (May 21, 2025), NVAX annual cost of goods sold is $202.74 million, with the most recent change of -$141.03 million (-41.02%) on December 31, 2024.
  • NVAX annual cost of goods sold is now -77.54% below its all-time high of $902.64 million, reached on December 31, 2022.

Performance

NVAX Cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

quarterly cost of goods sold:

$14.12M-$22.55M(-61.51%)
March 31, 2025

Summary

  • As of today (May 21, 2025), NVAX quarterly cost of goods sold is $14.12 million, with the most recent change of -$22.55 million (-61.51%) on March 31, 2025.
  • Over the past year, NVAX quarterly cost of goods sold has dropped by -$45.09 million (-76.16%).
  • NVAX quarterly cost of goods sold is now -96.75% below its all-time high of $434.59 million, reached on September 30, 2022.

Performance

NVAX quarterly cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

TTM cost of goods sold:

$157.65M-$45.09M(-22.24%)
March 31, 2025

Summary

  • As of today (May 21, 2025), NVAX TTM cost of goods sold is $157.65 million, with the most recent change of -$45.09 million (-22.24%) on March 31, 2025.
  • Over the past year, NVAX TTM cost of goods sold has dropped by -$211.25 million (-57.27%).
  • NVAX TTM cost of goods sold is now -82.89% below its all-time high of $921.52 million, reached on March 31, 2023.

Performance

NVAX TTM cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

Cost of goods sold Formula

COGS = Beginning Inventory + Purchases − Ending Inventory

NVAX Cost of goods sold Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-41.0%-76.2%-57.3%
3 y3 years--7.2%+936.9%
5 y5 years---

NVAX Cost of goods sold Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-77.5%at low-96.8%at low-82.9%+936.9%
5 y5-year-77.5%at low-96.8%at low-82.9%+936.9%
alltimeall time-77.5%>+9999.0%-96.8%+402.6%-82.9%>+9999.0%

NVAX Cost of goods sold History

DateAnnualQuarterlyTTM
Mar 2025
-
$14.12M(-61.5%)
$157.65M(-22.2%)
Dec 2024
$202.74M(-41.0%)
$36.67M(-39.5%)
$202.74M(-36.9%)
Sep 2024
-
$60.62M(+31.1%)
$321.05M(-10.7%)
Jun 2024
-
$46.24M(-21.9%)
$359.36M(-2.6%)
Mar 2024
-
$59.21M(-61.8%)
$368.89M(+7.3%)
Dec 2023
$343.77M(-61.9%)
$154.98M(+56.7%)
$343.77M(-7.2%)
Sep 2023
-
$98.93M(+77.4%)
$370.56M(-47.5%)
Jun 2023
-
$55.78M(+63.6%)
$706.22M(-23.4%)
Mar 2023
-
$34.09M(-81.2%)
$921.52M(+2.1%)
Dec 2022
$902.64M(+6043.7%)
$181.76M(-58.2%)
$902.64M(+25.2%)
Sep 2022
-
$434.59M(+60.3%)
$720.87M(+151.8%)
Jun 2022
-
$271.08M(+1682.9%)
$286.28M(+1782.9%)
Mar 2022
-
$15.20M(+277.6%)
$15.20M(+25.1%)
Sep 2014
-
$4.03M(-21.1%)
$12.15M(+16.8%)
Jun 2014
-
$5.10M(+68.9%)
$10.40M(+50.1%)
Mar 2014
-
$3.02M(+32.7%)
$6.93M(-8.5%)
Sep 2013
-
$2.28M(+39.5%)
$7.57M(-17.1%)
Jun 2013
-
$1.63M(-4.7%)
$9.13M(-27.6%)
Mar 2013
-
$1.71M(-12.3%)
$12.62M(-14.1%)
Dec 2012
$14.69M(+109.8%)
$1.95M(-49.1%)
$14.69M(-8.1%)
Sep 2012
-
$3.84M(-25.0%)
$15.98M(+11.5%)
Jun 2012
-
$5.12M(+35.2%)
$14.33M(+37.2%)
Mar 2012
-
$3.79M(+16.9%)
$10.45M(+49.2%)
Dec 2011
$7.00M(+3068.8%)
$3.24M(+47.9%)
$7.00M(+86.1%)
Sep 2011
-
$2.19M(+77.9%)
$3.76M(+139.1%)
Jun 2011
-
$1.23M(+258.9%)
$1.57M(+358.9%)
Mar 2011
-
$343.00K(-111.3%)
$343.00K(-132.8%)
Dec 2007
$221.00K(-6.8%)
-$3.05M(-378.1%)
-$1.05M(-21.0%)
Sep 2007
-
$1.10M(+28.2%)
-$1.33M(+5.9%)
Jun 2007
-
$855.00K(+1610.0%)
-$1.25M(+32.3%)
Mar 2007
-
$50.00K(-101.5%)
-$946.00K(-271.4%)
Dec 2006
$237.00K(-42.2%)
-$3.33M(-384.4%)
$552.00K(-170.3%)
Sep 2006
-
$1.17M(+0.8%)
-$785.00K(-11.5%)
Jun 2006
-
$1.16M(-25.0%)
-$887.00K(+4123.8%)
Mar 2006
-
$1.55M(-133.2%)
-$21.00K(-105.1%)
Dec 2005
$410.00K
-$4.66M(-536.7%)
$410.00K(-93.6%)
DateAnnualQuarterlyTTM
Sep 2005
-
$1.07M(-47.3%)
$6.44M(+12.3%)
Jun 2005
-
$2.03M(+2.4%)
$5.73M(+10.1%)
Mar 2005
-
$1.98M(+45.3%)
$5.21M(+49.2%)
Dec 2004
$3.49M(+69.7%)
$1.36M(+274.2%)
$3.49M(+24.6%)
Sep 2004
-
$364.00K(-75.7%)
$2.80M(-12.4%)
Jun 2004
-
$1.50M(+470.7%)
$3.20M(+53.4%)
Mar 2004
-
$263.00K(-60.9%)
$2.08M(+1.4%)
Dec 2003
$2.06M(-42.2%)
$673.00K(-11.6%)
$2.06M(-2.7%)
Sep 2003
-
$761.00K(+96.1%)
$2.11M(-0.0%)
Jun 2003
-
$388.00K(+65.8%)
$2.12M(-22.7%)
Mar 2003
-
$234.00K(-68.0%)
$2.73M(-23.1%)
Dec 2002
$3.56M(-12.2%)
$731.00K(-4.1%)
$3.56M(-10.0%)
Sep 2002
-
$762.00K(-24.4%)
$3.95M(-1.5%)
Jun 2002
-
$1.01M(-4.6%)
$4.01M(-1.3%)
Mar 2002
-
$1.06M(-6.1%)
$4.07M(+0.3%)
Dec 2001
$4.05M(-782.2%)
$1.13M(+37.0%)
$4.05M(+53.4%)
Sep 2001
-
$822.00K(-22.5%)
$2.64M(+53.9%)
Jun 2001
-
$1.06M(+1.7%)
$1.72M(+211.4%)
Mar 2001
-
$1.04M(-466.0%)
$551.00K(-192.8%)
Dec 2000
-$594.00K(+48.5%)
-$285.00K(+176.7%)
-$594.00K(+45.2%)
Sep 2000
-
-$103.00K(-1.0%)
-$409.00K(-19.2%)
Jun 2000
-
-$104.00K(+2.0%)
-$506.00K(+25.9%)
Mar 2000
-
-$102.00K(+2.0%)
-$402.00K(+0.5%)
Dec 1999
-$400.00K(+33.3%)
-$100.00K(-50.0%)
-$400.00K(0.0%)
Sep 1999
-
-$200.00K(+100.0%)
-$400.00K(+33.3%)
Mar 1999
-
-$100.00K(0.0%)
-$300.00K(0.0%)
Dec 1998
-$300.00K(0.0%)
-$100.00K(0.0%)
-$300.00K(-25.0%)
Jun 1998
-
-$100.00K(0.0%)
-$400.00K(+33.3%)
Mar 1998
-
-$100.00K(0.0%)
-$300.00K(0.0%)
Dec 1997
-$300.00K(0.0%)
-$100.00K(0.0%)
-$300.00K(0.0%)
Sep 1997
-
-$100.00K(0.0%)
-$300.00K(-25.0%)
Mar 1997
-
-$100.00K(0.0%)
-$400.00K(0.0%)
Dec 1996
-$300.00K
-$100.00K(0.0%)
-$400.00K(+33.3%)
Sep 1996
-
-$100.00K(0.0%)
-$300.00K(+50.0%)
Jun 1996
-
-$100.00K(0.0%)
-$200.00K(+100.0%)
Mar 1996
-
-$100.00K
-$100.00K

FAQ

  • What is Novavax annual cost of goods sold?
  • What is the all time high annual cost of goods sold for Novavax?
  • What is Novavax annual cost of goods sold year-on-year change?
  • What is Novavax quarterly cost of goods sold?
  • What is the all time high quarterly cost of goods sold for Novavax?
  • What is Novavax quarterly cost of goods sold year-on-year change?
  • What is Novavax TTM cost of goods sold?
  • What is the all time high TTM cost of goods sold for Novavax?
  • What is Novavax TTM cost of goods sold year-on-year change?

What is Novavax annual cost of goods sold?

The current annual cost of goods sold of NVAX is $202.74M

What is the all time high annual cost of goods sold for Novavax?

Novavax all-time high annual cost of goods sold is $902.64M

What is Novavax annual cost of goods sold year-on-year change?

Over the past year, NVAX annual cost of goods sold has changed by -$141.03M (-41.02%)

What is Novavax quarterly cost of goods sold?

The current quarterly cost of goods sold of NVAX is $14.12M

What is the all time high quarterly cost of goods sold for Novavax?

Novavax all-time high quarterly cost of goods sold is $434.59M

What is Novavax quarterly cost of goods sold year-on-year change?

Over the past year, NVAX quarterly cost of goods sold has changed by -$45.09M (-76.16%)

What is Novavax TTM cost of goods sold?

The current TTM cost of goods sold of NVAX is $157.65M

What is the all time high TTM cost of goods sold for Novavax?

Novavax all-time high TTM cost of goods sold is $921.52M

What is Novavax TTM cost of goods sold year-on-year change?

Over the past year, NVAX TTM cost of goods sold has changed by -$211.25M (-57.27%)
On this page